-
公开(公告)号:US20190330372A1
公开(公告)日:2019-10-31
申请号:US16472646
申请日:2017-12-21
Applicant: Novartis AG
Inventor: Maximillian AIGNER , Alexander Wolfgang KOCH , Markus WALDHUBER
Abstract: The present disclosure relates to monoclonal antibodies and antigen binding fragments thereof that bind to human Factor XI and activated Factor XI (“Factor XIa”), and pharmaceutical compositions and methods of treatment comprising the same.